Theravance Biopharma, Inc.

TBPH

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001583107

SEC filings (opens in a new tab)

In the last 90 days, Theravance Biopharma, Inc. insiders filed 0 open-market purchases and 2 sales; 179 institutions reported holding it in 13F filings for Q2 2026, worth $817.5M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Theravance Biopharma, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024 All holders in Q1 2024

13F holders of TBPH: Q1 2024 compared with Q2 2024
Measure	Q1 2024	Of which not filed for Q2 2024	Q2 2024	Change
Holders	121	1	132	+12
Shares	48.0M	115.4K	47.1M	−763.6K (−1.6%)
Value	$430.6M	$1.04M	$399.5M	−$30.0M (−7.0%)

1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (25)

Institutions that held Theravance Biopharma, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to TBPH in Q2 2024
Institution	Shares	Value	% of portfolio
Gsa Capital Partners LLP	204,089	$1.73M	0.12%
Squarepoint Ops LLC	116,256	$985.9K	0.00%
Sherbrooke Park Advisers LLC	52,518	$445.4K	0.08%
Two Sigma Investments, LP	49,523	$420.0K	0.00%
Mirae Asset Global ETFs Holdings Ltd.	43,266	$366.9K	0.00%
Alps Advisors Inc	37,944	$321.8K	0.00%
Verition Fund Management LLC	34,336	$291.2K	0.00%
Two Sigma Advisers, LP	33,900	$287.5K	0.00%
Los Angeles Capital Management LLC	33,760	$286.3K	0.00%
Trexquant Investment LP	33,522	$284.3K	0.00%
Corebridge Financial, Inc.	19,757	$167.5K	0.00%
Nebula Research & Development LLC	18,154	$153.9K	0.02%
Inceptionr LLC	17,435	$147.8K	0.04%
Connor, Clark & Lunn Investment Management Ltd.	16,023	$135.9K	0.00%
Susquehanna International Group, LLP	15,199	$128.9K	0.00%
XTX Topco Ltd	15,196	$128.9K	0.01%
HSBC Holdings PLC	12,829	$107.8K	0.00%
Centiva Capital, LP	12,139	$102.9K	0.00%
Occudo Quantitative Strategies LP	10,849	$92.0K	0.02%
State of Wyoming	4,951	$42.0K	0.01%
Point72 (DIFC) Ltd	1,824	$15.5K	0.00%
Simplex Trading, LLC	334	$2.00K	0.00%
Smartleaf Asset Management LLC	237	$1.97K	0.00%
SRS Capital Advisors, Inc.	57	$484	0.00%
Lindbrook Capital, LLC	53	$449	0.00%

Sold out (13)

Institutions that held Theravance Biopharma, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of TBPH in Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
Jump Financial, LLC	43,447	$389.7K
Assenagon Asset Management S.A.	40,166	$360.3K
American International Group, Inc.	23,942	$214.8K
Corton Capital Inc.	14,888	$133.5K
Principal Financial Group Inc	14,708	$131.9K
ProShare Advisors LLC	12,219	$109.6K
Atom Investors LP	11,576	$103.8K
Catalyst Funds Management Pty Ltd	11,410	$102.3K
Man Group plc	10,101	$90.6K
Cubist Systematic Strategies, LLC	5,834	$52.3K
Metropolitan Life Insurance Co	2,773	$24.9K
Newbridge Financial Services Group, Inc.	1,000	$8.97K
Nelson, Van Denburg & Campbell Wealth Management Group, LLC	13	$116

Not filed for Q2 2024 yet (1)

Institutions that held Theravance Biopharma, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TBPH in Q1 2024 that haven't filed for Q2 2024
Institution	Shares, Q1 2024	Value, Q1 2024
Credit Suisse AG	115,418	$1.04M